Recursion Pharmaceuticals CEO explains how AI could make drug development faster and less costly
May 10, 2024 at 19:06 PM EDT
In a Friday interview with CNBC's Jim Cramer, Recursion Pharmaceuticals CEO Chris Gibson explained how his company uses new AI technology to develop drugs.
